Qube Research & Technologies LTD Haleon PLC Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Haleon PLC stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,318,738 shares of HLN stock, worth $13.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,318,738
Previous 201,990
552.87%
Holding current value
$13.5 Million
Previous $2.14 Million
489.94%
% of portfolio
0.02%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding HLN
# of Institutions
662Shares Held
417MCall Options Held
269KPut Options Held
40.6K-
Dodge & Cox San Francisco, CA179MShares$1.83 Billion1.07% of portfolio
-
Clearbridge Investments, LLC New York, NY32.8MShares$336 Million0.26% of portfolio
-
Harding Loevner LP Bridgewater, NJ24.1MShares$247 Million1.6% of portfolio
-
Morgan Stanley New York, NY9.89MShares$101 Million0.01% of portfolio
-
Sculptor Capital LP New York, NY8.89MShares$91 Million2.49% of portfolio
About Haleon plc
- Ticker HLN
- Exchange
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 4,617,290,240
- Market Cap $47.3B
- Description
- Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...